argenx vs Viridian Therapeutics, Inc.
argenx vs Viridian Therapeutics, Inc., compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: argenx is on 49/100 and Viridian Therapeutics, Inc. on 43/100.
Where each one leads
argenx
- our overall score: 49/100 against 43/100
- domain rating: 66/100 against 42/100
Viridian Therapeutics, Inc.
- agent readiness: 39/100 against 32/100
- funding raised: $350M against $51.1M
At a glance
| Measure | argenx | Viridian Therapeutics, Inc. |
|---|---|---|
| What it is | Global immunology company developing antibody-based therapies for severe autoimmune diseases. | Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease. |
| Category | BiTech, Biopharmaceuticals, Immunology, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Software | hardware | services | marketplace | platform |
| Founded | 2008 | 2017 |
| Headquarters | Amsterdam, Netherlands | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | argenx | Viridian Therapeutics, Inc. |
|---|---|---|
| Total funding | $51.1M | $350M |
| Latest round | Series B | Public Offering |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | argenx | Viridian Therapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 43/100 |
| Traction | 39/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 5/100 | 13/100 |
| Quality | 58/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 42/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | argenx | Viridian Therapeutics, Inc. |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Tailwind CSS, Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
argenx vs Viridian Therapeutics, Inc.: common questions
Which is better, argenx or Viridian Therapeutics, Inc.?
On our 0-100 score argenx rates higher (49/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do argenx and Viridian Therapeutics, Inc. compare on the numbers?
argenx leads on our overall score (49/100 against 43/100), domain rating (66/100 against 42/100). Viridian Therapeutics, Inc. leads on agent readiness (39/100 against 32/100), funding raised ($350M against $51.1M).
Read the full argenx review and pricing or the Viridian Therapeutics, Inc. review and pricing. You can also browse other argenx alternatives we track.